Drug General Information
Drug ID
D0L5MF
Former ID
DIB005198
Drug Name
PYRAZOLOACRIDINE
Synonyms
PZA; PD-115934; 2-[3-(Dimethylamino)propyl]-9-methoxy-5-nitro-2,6-dihydropyrazolo[3,4,5-kl]acridine; 9-Methoxy-N,N-dimethyl-5-nitro-2,6-dihydropyrazolo[3,4,5-kl]acridine-2-propanamine
Drug Type
Small molecular drug
Indication Colorectal cancer [ICD9: 153, 154; ICD10:C18-C21] Phase 2 [521455]
Structure
Download
2D MOL

3D MOL

Formula
C19H21N5O3
Canonical SMILES
CN(C)CCCN1C2=C3C(=C4C=C(C=CC4=NC3=C(C=C2)[N+](=O)[O-])O<br />C)N1
InChI
1S/C19H21N5O3/c1-22(2)9-4-10-23-15-7-8-16(24(25)26)19-17(15)18(21-23)13-11-12(27-3)5-6-14(13)20-19/h5-8,11,21H,4,9-10H2,1-3H3
InChIKey
HVRZAFDJOWIDMM-UHFFFAOYSA-N
CAS Number
CAS 99009-20-8
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) DNA topoisomerase II Target Info Modulator [534593]
References
Ref 521455ClinicalTrials.gov (NCT00003802) Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma. U.S. National Institutes of Health.
Ref 534593Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II. Clin Cancer Res. 1998 Mar;4(3):683-91.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.